Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Merck: Hold For Quality, 11-Year Dividend Growth And 2.5% Yield
01:13pm, Wednesday, 30'th Nov 2022
Merck & Co., Inc. offers 11 years of rising dividends, 8.2% 5-year dividend growth rate, and 2.5% yield. Merck has a winning earnings yield of 6.7% and is near fair value price from Value Line.
Three-Stock Lunch: PayPal, Merck and Broadcom
03:36pm, Tuesday, 29'th Nov 2022
Quint Tatro, Joule Financial founder and CEO, joins 'Power Lunch' to discuss his investing take on three stocks: PayPal, Merck and Broadcom.
Is Merck Stock A Buy After Surging To A Fresh High On Its Imago Buyout Plans?
01:50pm, Tuesday, 29'th Nov 2022
Is Merck stock a buy after the company announced its acquisition of Imago, a bone marrow diseases company? Is MRK stock a buy now?
Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now?
10:32am, Tuesday, 29'th Nov 2022
Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.
3 Dow Stocks to Take Seriously in 2023
09:41am, Tuesday, 29'th Nov 2022
The Dow Jones Industrial Average is down more than 6% year-to-date. With slightly more than half of the index in negative territory for the year, it is easier to come up with three of the top Dow stoc
Rallying Merck Stock Flashing Historically Bullish Signal
01:59pm, Monday, 28'th Nov 2022
A week after announcing its acquisition of Imago Biosciences (IMGO), things are looking up for pharmaceutical concern Merck & Co Inc (NYSE:MRK).
3 Biotech Stocks Smart Investors Should Be Buying Up Now
01:51am, Thursday, 24'th Nov 2022
For investors looking for growth, biotech stocks are a great place to start one's search. This is a sector that's seen its valuation multiples decline in many cases to a greater extent than the overa
We Just Bought These 3 Dividend And Growth Stocks
01:54pm, Wednesday, 23'rd Nov 2022
High interest rates have been a significant headwind for high PE names in 2022. The pain is likely to continue in 2023. Multiple contraction is largely to blame in 2022. We expect yields to remain e
Merck (MRK) Keytruda Advanced Gastric Cancer Study Meets Goal
01:33pm, Wednesday, 23'rd Nov 2022
Top-line data from a late-stage study shows that Merck's (MRK) Keytruda combined with chemotherapy improved overall survival in patients with advanced gastric cancer.
3 Undervalued Dow Stocks to Buy Before Wall Street Catches On
06:59pm, Tuesday, 22'nd Nov 2022
The Dow Jones Industrial Average is down around 6.2% year to date. Of the 30 stocks in the index, 14 are down at least 10% for the year.
China's three-week COVID case tally tops 253,000 and daily average is rising, government says
03:10pm, Tuesday, 22'nd Nov 2022 MarketWatch
More than 253,000 coronavirus cases have been found in China in the past three weeks and the daily average is rising
Buy These 5 Corporate Giants Flying High in Disappointing 2022
01:06pm, Tuesday, 22'nd Nov 2022 Zacks Investment Research
We have narrowed our search to five U.S. corporate behemoths that have popped year to date. These are: ADM, MPC, XOM, MRK and MCK.
AbbVie (ABBV) BLA for Epcoritamab Gets FDA Priority Tag
11:15am, Tuesday, 22'nd Nov 2022 Zacks Investment Research
The FDA grants priority review status to AbbVie's (ABBV) BLA for epcoritamab for the relapsed/refractory large B-cell lymphoma (LBCL), a form of NHL.
Buy These 5 Corporate Giants Flying High in Disappointing 2022
09:47am, Tuesday, 22'nd Nov 2022
We have narrowed our search to five U.S. corporate behemoths that have popped year to date. These are: ADM, MPC, XOM, MRK and MCK.
Japan approves COVID antiviral pill as Pfizer, Merck alternative
07:24am, Tuesday, 22'nd Nov 2022
TOKYO—Japan approved an antiviral pill from Shionogi & Co. to treat Covid-19 after the company provided new data to show the drug's efficacy.
